T2 hyperintensities: Findings and significance

Neuroimaging Clinics of North America

Volumn 10, Issue 4, 2000, Pages 717-738

  Li, D K B ^a   Zhao, G ^a   Paty, D W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REVIEW;

BRAIN; CEREBRAL VENTRICLES; DIAGNOSIS, DIFFERENTIAL; ECHO-PLANAR IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS; SENSITIVITY AND SPECIFICITY;

EID: 0034446568     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging
2. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
3. Fast spinecho and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions
4. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis
5. Topological characteristics of brainstem lesions in clinically definite and clinically probable cases of multiple sclerosis: An MRI-study
6. The distribution of plaques in the cerebrum in multiple sclerosis
7. Ventricular size, cognitive function and depression in patients with multiple sclerosis
8. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
9. Placebo-controlled multicenter randomized trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
10. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis
11. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
12. Axonal damage in acute multiple sclerosis lesions
13. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis
14. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow up study
15. Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis
16. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery
17. Multiple sclerosis lesion detection in the brain: A comparison of fast fluid attenuated inversion recovery and conventional T2-weighted dual spin echo
18. Abnormal corpus callosum: A sensitive and specific indicator of multiple sclerosis
19. Distributional patterns of multiple sclerosis brain lesions. Magnetic resonance imaging - Clinical correlation
20. North American study group on interferon beta-1b in secondary progressive MS: Interferon beta-1b in secondary progressive multiple sclerosis: Clinical and MRI results in a 3-year randomized controlled trial
21. Multiple sclerosis: Gadolinium enhancement in MR imaging
22. Serial gadolinium enhanced magnetic resonance imaging scans in patients with early relapsing/remitting multiple sclerosis: Implications for clinical trials and natural history
23. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis
24. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders
25. The ovoid lesion: A new MR observation in patients with MS
26. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
27. Interferon-β-1b in the treatment of multiple sclerosis: Final outcome of the randomised controlled trial
28. Multiple sclerosis: A serial study using MRI in relapsing patients
29. Intramuscular interferon-β-1a for disease progression in relapsing multiple sclerosis
30. Magnetic resonance imaging: Serial observations in multiple sclerosis
31. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
32. Heterogeneity of blood-brain barrier changes in multiple sclerosis: A MRI study with gadolinium-DTPA enhancement
33. Spinal cord MRI using multi-array coils and fast spin echo. II: Findings in multiple sclerosis
34. MRI dynamics of brain and spinal cord in progressive multiple sclerosis
35. Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months
36. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features
37. The lesion of multiple sclerosis: Imaging of acute and chronic stages
38. The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis
39. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
40. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
41. Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-beta la in relapsing remitting multiple sclerosis
42. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression
43. Using gadolinium enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
44. In vivo visualization of myelin water in brain by magnetic resonance
45. Correlation between brain MRI lesion volume and disability in patients with multiple sclerosis
46. Comparison of the FAISE method with conventional dual spinecho images
47. Isolated U-fiber involvement in MS: Preliminary observations
48. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis
49. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
50. Effect of interferon β-1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial
51. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study
52. Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy
53. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue
54. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
55. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions
56. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
57. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
58. Magnetic resonance imaging (MRI) as an outcome measure in multiple sclerosis
59. Magnetic resonance imaging changes as living pathology in multiple sclerosis
60. Diagnosis of multiple sclerosis 1998: Do we need new diagnostic criteria?
61. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
62. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/ remitting multiple sclerosis
63. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis
64. Neuropsychology of multiple sclerosis: A critical review
65. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis
66. Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods
67. A comparison between the sensitivity of 3-mm and 5-mm thick serial brain MRI for detecting lesion volume changes in patients with multiple sclerosis
68. Contrast optimization of fluid-attenuated inversion recovery (FLAIR) imaging
69. Corpus callosum and subcallosal periventricular lesions in multiple sclerosis: Detection with MR
70. Neuroimaging of multiple sclerosis
71. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis
72. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions
73. Spinal cord atrophy and disability in MS: A longitudinal study
74. Correlation between NMR scan and brain slices: Data in multiple sclerosis
75. Magnetic resonance imaging (MRI) in multiple sclerosis (MS): Pathological correlation studies in eight cases
76. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis
77. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters
78. Multiple sclerosis of the spinal cord: Magnetic resonance appearance
79. Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study
80. Major differences in the dynamics of primary and secondary progressive multiple sclerosis
81. Serial gadolinium enhanced MRI in relapsing remitting multiple sclerosis of varying disease duration
82. A comparison between fast spin-echo and conventional spin-echo in the detection of multiple sclerosis lesions
83. Quantitative MRI in optic neuritis: Correlation with clinical findings and electrophysiology
84. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis
85. Axonal transection in the lesions of multiple sclerosis
86. A comparison between magnetization transfer ratio and myelin water percentages in normals and multiple sclerosis patients
87. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients
88. Nuclear magnetic resonance imaging of the brain in multiple sclerosis
89. The growth pattern of enlarging lesions in multiple sclerosis: Observation on serial MRI
90. Corticospinal tract lesions in multiple sclerosis: Relationship between MRI activity and clinical course
91. Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis
92. Correlation of clinical status with MS lesion changes in untreated patients: A 5-year study by yearly MRI
93. Relapsing-remitting MS is more active than secondary-progressive MS on gadolinium enhanced MRI
94. Comparison of baseline magnetic resonance imaging burden of disease and proton density and T2-weighted lesion activity between patients with relapsing-remitting and secondary progressive multiple sclerosis at the time of entry into therapeutic trails
95. Effect of interferon β-1b in MS: Assessment of annual accumulation of PD/T2 activity on MRI
96. MRI of dirty-appearing white matter in MS